BlackRock’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66M Sell
1,575,989
-180,385
-10% -$6.98M ﹤0.01% 2492
2026
Q1
$66.1M Buy
1,756,374
+13,516
+0.8% +$442K ﹤0.01% 2335
2025
Q4
$52.4M Buy
1,742,858
+194,817
+13% +$5.51M ﹤0.01% 2486
2025
Q3
$40.6M Buy
1,548,041
+635,766
+70% +$15.2M ﹤0.01% 2631
2025
Q2
$19.4M Buy
912,275
+378,254
+71% +$8.54M ﹤0.01% 3047
2025
Q1
$11.4M Buy
534,021
+45,698
+9% +$938K ﹤0.01% 3253
2024
Q4
$9.89M Buy
+488,323
New +$10.1M ﹤0.01% 3436

Other funds holding GRDN

BlackRock's GRDN Position: Q2 2026 in Review

BlackRock reduced its Guardian Pharmacy Services (GRDN) stake by 10% in Q2 2026, selling an estimated $6.98M and leaving 1,575,989 shares worth $66M. The position accounts for ﹤0.01% of the portfolio, ranked #2492.

BlackRock first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. The position peaked at $66.1M in Q1 2026. 189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • BlackRock held 1,575,989 shares of Guardian Pharmacy Services worth $66M as of Q2 2026.
  • BlackRock sold 180,385 Guardian Pharmacy Services shares in Q2 2026, an estimated $6.98M.
  • Guardian Pharmacy Services made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2492 holding.
  • BlackRock first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • BlackRock's Guardian Pharmacy Services position peaked at $66.1M in Q1 2026.
  • 189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.